A Lancet study published Sept. 25 indicates that few in the U.S. adult population formed antibodies against SARS-CoV-2, at least during the virus’ first wave in this country. Researchers found that, as of July, the national average of Americans with SARS-CoV-2 antibodies was 9.3%.

The researchers also observed racial and economic differences, with residents in predominantly Black and Hispanic neighborhoods two-to-three times more likely than white Americans to have antibodies; the same was true for those in poorer communities, compared to those who are wealthy.

"This research clearly confirms that despite high rates of COVID-19 in the United States, the number of people with antibodies is still low and we haven't come close to achieving herd immunity," Julie Parsonnet, M.D., one of the study’s authors. “Until an effective vaccine is approved, we need to make sure our more vulnerable populations are reached with prevention measures.”

Related News Articles

Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…